Acadia Healthcare (NASDAQ:ACHC) Cut to Hold at Leerink Partnrs

Leerink Partnrs lowered shares of Acadia Healthcare (NASDAQ:ACHC) from a strong-buy rating to a hold rating in a research note issued to investors on Wednesday,Zacks.com reports.

A number of other equities research analysts also recently commented on ACHC. Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a research report on Wednesday. Cowen restated a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Royal Bank Of Canada dropped their price objective on shares of Acadia Healthcare from $22.00 to $19.00 and set an “outperform” rating for the company in a research note on Wednesday. Raymond James Financial set a $17.00 target price on shares of Acadia Healthcare in a research report on Wednesday. Finally, Barclays dropped their price target on shares of Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating for the company in a research report on Thursday, November 6th. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $23.17.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $15.47 on Wednesday. The company has a 50-day simple moving average of $20.68 and a 200-day simple moving average of $21.72. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The company has a market cap of $1.43 billion, a PE ratio of 13.22, a price-to-earnings-growth ratio of 3.45 and a beta of 0.91. Acadia Healthcare has a 12 month low of $12.63 and a 12 month high of $47.08.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently made changes to their positions in the business. LPL Financial LLC raised its stake in shares of Acadia Healthcare by 1.2% in the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock valued at $1,651,000 after acquiring an additional 697 shares during the period. XTX Topco Ltd raised its position in Acadia Healthcare by 7.3% in the first quarter. XTX Topco Ltd now owns 14,570 shares of the company’s stock valued at $442,000 after purchasing an additional 994 shares during the period. PNC Financial Services Group Inc. raised its position in Acadia Healthcare by 10.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock valued at $202,000 after purchasing an additional 622 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Acadia Healthcare by 4.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,289,029 shares of the company’s stock worth $39,083,000 after purchasing an additional 54,806 shares in the last quarter. Finally, Headlands Technologies LLC grew its stake in shares of Acadia Healthcare by 6,982.6% in the first quarter. Headlands Technologies LLC now owns 25,993 shares of the company’s stock valued at $788,000 after buying an additional 25,626 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.